Literature DB >> 18498808

Coronary artery bypass grafting is associated with excellent long-term survival and quality of life: a prospective cohort study.

Joel Dunning1, Julian R L Waller, Barbara Smith, Sue Pitts, Simon W H Kendall, Khalid Khan.   

Abstract

BACKGROUND: We investigated the long-term outcome of coronary artery bypass grafting both in terms of survival and quality of life.
METHODS: Ten-year postsurgery survival was collated on patients undergoing coronary artery bypass grafting from 1994 to 1996, and quality of life was assessed using EQ-5D and a quality-of-life thermometer. We analyzed data from 1,180 patients. Mean age was 61 years, and 79% had triple-vessel disease.
RESULTS: Thirty-day mortality was 3.3% (1.8% elective). Mean time to censorship for survivors was 9.9 years (range, 8.1 to 12.3 years). Ten-year survival was 66% across all patients, 70% for elective patients. Ten-year cardiac survival was 82%. Percutaneous intervention was required in 25 patients in the subsequent 10 years (2%), and only 4 required redo coronary artery bypass grafting (0.3%); 59% of patients reported no angina, and 88% of patients had grade II angina or better. Of 621 patients who were assessed for quality of life at 10 years, 530 (85%) had a quality of life within a 95% confidence interval of the score found in the general population with similar age. Poor quality of life was reported in 91 patients (14.7%). Significant predictors of poor long-term quality of life were current smoking, Canadian Cardiovascular Society grade III or IV, redo operation, female sex, diabetes, peripheral vascular disease, more than 2 days in intensive care, and chronic obstructive pulmonary disease. Twenty-five percent of patients with poor EQ-5D outcome had grade IV angina. Interestingly, age did not correlate with poor outcome, and administration of blood, arterial revascularization, left mainstem disease, or cross-clamp fibrillation had no impact on survival or outcome.
CONCLUSIONS: Coronary artery bypass grafting is associated with excellent 10-year survival and quality of life.

Entities:  

Mesh:

Year:  2008        PMID: 18498808     DOI: 10.1016/j.athoracsur.2008.02.024

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

Review 1.  Does coronary artery bypass grafting improve quality of life in elderly patients?

Authors:  Kamran Baig; Leanne Harling; Joseph Papanikitas; Saina Attaran; Hutan Ashrafian; Roberto Casula; Thanos Athanasiou
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-05-27

2.  Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi-centre randomized double-blinded controlled clinical trial.

Authors:  Derek J Hausenloy; Luciano Candilio; Chris Laing; Gudrun Kunst; John Pepper; Shyam Kolvekar; Richard Evans; Steve Robertson; Rosemary Knight; Cono Ariti; Tim Clayton; Derek M Yellon
Journal:  Clin Res Cardiol       Date:  2011-12-21       Impact factor: 5.460

Review 3.  Predictors of health-related quality of life after cardiac surgery: a systematic review.

Authors:  Julie Sanders; Tracey Bowden; Nicholas Woolfe-Loftus; Mandeep Sekhon; Leanne M Aitken
Journal:  Health Qual Life Outcomes       Date:  2022-05-18       Impact factor: 3.077

4.  Multivariate Meta-Analysis of Preference-Based Quality of Life Values in Coronary Heart Disease.

Authors:  Jelena Stevanović; Petros Pechlivanoglou; Marthe A Kampinga; Paul F M Krabbe; Maarten J Postma
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

Review 5.  A review of health utilities using the EQ-5D in studies of cardiovascular disease.

Authors:  Matthew T D Dyer; Kimberley A Goldsmith; Linda S Sharples; Martin J Buxton
Journal:  Health Qual Life Outcomes       Date:  2010-01-28       Impact factor: 3.186

6.  Outcomes and long-term survival of coronary artery surgery: The controversial role of opium as risk marker.

Authors:  Mahdi Najafi; Leila Jahangiry; Seyedeh Hamideh Mortazavi; Arash Jalali; Abbasali Karimi; Ali Bozorgi
Journal:  World J Cardiol       Date:  2016-11-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.